Jeil Pharmaceutical Co.,Ltd (KRX:271980)

Market Cap	205.90B
Revenue (ttm)	621.98B
Net Income (ttm)	19.64B
Shares Out	14.57M
EPS (ttm)	1,347.46
PE Ratio	10.49
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,472
Average Volume	26,156
Open	14,100
Previous Close	14,000
Day's Range	13,950 - 14,300
52-Week Range	10,120 - 17,800
Beta	0.56
RSI	47.68
Earnings Date	Nov 14, 2025

About KRX:271980

Jeil Pharmaceutical Co.,Ltd develops and supplies pharmaceutical products primarily in South Korea. It provides products in the areas of antibiotic, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamine. The company also exports its products to approximately 40 countries in ASEAN, Central and South America, Africa, and internationally. Jeil Pharmaceutical Co.,Ltd was founded in 1959 and is headquartered in Seoul, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1959
• Employees: 947
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 271980